ITRM20020511A0 - Uso dell'insulator sns di riccio di mare per la terapia genica di malattie delle cellule eritroidi. - Google Patents

Uso dell'insulator sns di riccio di mare per la terapia genica di malattie delle cellule eritroidi.

Info

Publication number
ITRM20020511A0
ITRM20020511A0 IT2002RM000511A ITRM20020511A ITRM20020511A0 IT RM20020511 A0 ITRM20020511 A0 IT RM20020511A0 IT 2002RM000511 A IT2002RM000511 A IT 2002RM000511A IT RM20020511 A ITRM20020511 A IT RM20020511A IT RM20020511 A0 ITRM20020511 A0 IT RM20020511A0
Authority
IT
Italy
Prior art keywords
sns
gene therapy
sea urchin
erythroid cell
cell diseases
Prior art date
Application number
IT2002RM000511A
Other languages
English (en)
Inventor
Aurelio Maggio
Santa Anna Acuto
Marzo Rosalba Di
Giovanni Spinelli
Original Assignee
Aurelio Maggio
Santa Anna Acuto
Marzo Rosalba Di
Giovanni Spinelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurelio Maggio, Santa Anna Acuto, Marzo Rosalba Di, Giovanni Spinelli filed Critical Aurelio Maggio
Priority to IT000511A priority Critical patent/ITRM20020511A1/it
Publication of ITRM20020511A0 publication Critical patent/ITRM20020511A0/it
Priority to AU2003279536A priority patent/AU2003279536A1/en
Priority to PCT/IT2003/000611 priority patent/WO2004032973A2/en
Publication of ITRM20020511A1 publication Critical patent/ITRM20020511A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IT000511A 2002-10-09 2002-10-09 Uso dell'insulator sns di riccio di mare per la terapia genica di malattie delle cellule eritroidi. ITRM20020511A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT000511A ITRM20020511A1 (it) 2002-10-09 2002-10-09 Uso dell'insulator sns di riccio di mare per la terapia genica di malattie delle cellule eritroidi.
AU2003279536A AU2003279536A1 (en) 2002-10-09 2003-10-09 Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases
PCT/IT2003/000611 WO2004032973A2 (en) 2002-10-09 2003-10-09 Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000511A ITRM20020511A1 (it) 2002-10-09 2002-10-09 Uso dell'insulator sns di riccio di mare per la terapia genica di malattie delle cellule eritroidi.

Publications (2)

Publication Number Publication Date
ITRM20020511A0 true ITRM20020511A0 (it) 2002-10-09
ITRM20020511A1 ITRM20020511A1 (it) 2004-04-10

Family

ID=11456518

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000511A ITRM20020511A1 (it) 2002-10-09 2002-10-09 Uso dell'insulator sns di riccio di mare per la terapia genica di malattie delle cellule eritroidi.

Country Status (3)

Country Link
AU (1) AU2003279536A1 (it)
IT (1) ITRM20020511A1 (it)
WO (1) WO2004032973A2 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2694108B1 (en) * 2011-04-08 2018-06-06 University Of Leicester Methods for treating conditions associated with masp-2 dependent complement activation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE466089T1 (de) * 2000-12-22 2010-05-15 Agronomique Inst Nat Rech Positionsunabhängige und gewebespezifische expression eines transgens in der milch eines transgen-tieres

Also Published As

Publication number Publication date
WO2004032973A3 (en) 2004-09-16
AU2003279536A1 (en) 2004-05-04
ITRM20020511A1 (it) 2004-04-10
WO2004032973A2 (en) 2004-04-22
AU2003279536A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
IS7298A (is) Platínuafleiða lyfjasamsetningar
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
CR8102A (es) Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
IT1318514B1 (it) Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
ITNA20000036A0 (it) Nuovi approcci terapeutici per il trattamento della forfora.
NO20041773L (no) Farmasoytiske preparater for reduksjon av cellers aktivitet samt deres anvendelse.
ATE325115T1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
ITMI20031388A1 (it) Formulazioni per il trattamento e la prevenzione di patologie della prostata.
ITRM20020511A0 (it) Uso dell'insulator sns di riccio di mare per la terapia genica di malattie delle cellule eritroidi.
NO20035352D0 (no) Legemidler for eosinofile sykdommer
ITMI20030778A1 (it) Procedimento per la preparazione enzimatica dell'aroma di vaniglia.
ITMI20022411A1 (it) Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
DE60312645D1 (de) Darreichungsformen für dns
IS8225A (is) 2-etoxý-3-fenýlprópíónsýruafleiður til að meðhöndla fitusjúkdóma
NO20032035D0 (no) Terapeutiske midler for heratokonjunktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens